Lifecore Biomedical Inc [LFCR] stock prices are up 1.48% to $8.22 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LFCR shares have gain 8.73% over the last week, with a monthly amount glided 6.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 05, 2024, Craig Hallum initiated with a Buy rating and assigned a price target of $8 on the stock. Barrington Research downgraded its rating to a Mkt Perform. Stephens downgraded its rating to a Equal-Weight and reduced its price target to $2 on March 20, 2023.
The stock price of Lifecore Biomedical Inc [LFCR] has been fluctuating between $4.76 and $8.85 over the past year. Currently, Wall Street analysts expect the stock to reach $6.5 within the next 12 months. Lifecore Biomedical Inc [NASDAQ: LFCR] shares were valued at $8.22 at the most recent close of the market. An investor can expect a potential drop of -20.92% based on the average LFCR price forecast.
Analyzing the LFCR fundamentals
The Lifecore Biomedical Inc [NASDAQ:LFCR] reported sales of 128.87M for trailing twelve months, representing a surge of 25.92%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -2.33 and Total Capital is -0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Lifecore Biomedical Inc [NASDAQ:LFCR]’s Current Ratio is 2.80. In addition, the Quick Ratio stands at 1.67 and the Cash Ratio stands at 0.63. Considering the valuation of this stock, the price to sales ratio is 2.39.
Transactions by insiders
Recent insider trading involved English Aron R., 10% Owner, that happened on May 27 ’25 when 1.14 million shares were sold. 10% Owner, English Aron R. completed a deal on May 28 ’25 to sell 0.15 million shares. Meanwhile, 10% Owner English Aron R. sold 96137.0 shares on May 23 ’25.
